CVE-2024-45642

Name: CVE-2024-45642
Creator: NVD / NIST
Published: 2024-11-14T12:15:18.323+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 5.3/10EPSS 0.47%

Last modified Jun 17, 2026

CVE-2024-45642 is a medium-severity vulnerability rated 5.3/10 on the CVSS scale. IBM Security ReaQta 3.12 is vulnerable to cross-site scripting. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.. EPSS estimates a 0.47% chance of exploitation in the next 30 days.

Description

IBM Security ReaQta 3.12 is vulnerable to cross-site scripting. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Metrics

CVSS 3.1

5.3/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

EPSS Probability

0.47%

37.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-942

Affected Software

Vendor	Product	Versions
Ibm	Security Qradar Edr	>= 3.12, < 3.12.12

References

https://www.ibm.com/support/pages/node/7172212Vendor Advisory

Timeline

Published: Nov 14, 2024
Last Modified: Jun 17, 2026
Status: Analyzed

Frequently Asked Questions

What is CVE-2024-45642?

How severe is CVE-2024-45642?

CVE-2024-45642 has a CVSS score of 5.3/10 (MEDIUM severity). The EPSS model estimates a 0.47% probability of exploitation in the next 30 days.

How do I fix CVE-2024-45642?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2024-45642?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST